Piperidine/piperazine-type inhibitors of p38 kinase

Details Piperidine/piperazine-type inhibitors of p38 kinase Piperidine/piperazine-type inhibitors of p38 kinase

2007-05-08

2007-05-08

Habte, Kahsay (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S360000, C544S363000, C544S364000, C544S368000, C544S369000, C544S370000, C544S376000, C544S379000, C544S371000, C544S372000, C544S391000, C514S253050, C514S253060, C514S253100, C514S253090, C514S253110, C514S254040, C514S254020, C514S254050

Reexamination Certificate

active

10757023

ABSTRACT:
Compounds of the formula:wherein the substituents are as defined herein are useful for treating conditions mediated by p38 kinase.

REFERENCES:
patent: 5340809 (1994-08-01), Gaudry et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 0 512 352 (1992-11-01), None
patent: WO 96/40143 (1996-12-01), None
patent: WO 97/26252 (1997-07-01), None
patent: WO 98/06715 (1998-02-01), None
patent: WO 98/07425 (1998-02-01), None
patent: WO 99/31096 (1999-06-01), None
patent: WO 99/61426 (1999-12-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/59904 (2000-10-01), None
patent: WO 00/71535 (2000-11-01), None
Scott et al. (1995).Journal of Medicinal Chemistry38(21):4198-4210.
Chalmers (1996).TIPS17:166-172.

Affiliated with

Also associated with

Rating

Piperidine/piperazine-type inhibitors of p38 kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine/piperazine-type inhibitors of p38 kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine/piperazine-type inhibitors of p38 kinase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3785255